Dr. Marlena Fejzo, HER Foundation’s Research Director, Harmonia Healthcare’s Chief Scientific Officer, and an Assistant Professor at USC has been honored as one of Forbes 50 over 50: Innovation!
Discover the full Forbes 50 over 50 list: msnbc.com/knowyourvalue
This is truly exciting news, and we are incredibly proud of Dr. Marlena Fejzo! Over the past years, Dr. Fejzo’s decades of research in collaboration with the HER Foundation has given the HG community hope for a cure! The groundbreaking research brings us closer to understanding and ultimately preventing or at least greatly reducing the symptoms of HG in the future. Dr. Fejzo and her team are one of the only groups doing this research in the world! As we celebrate this monumental achievement, we encourage you to support our vital work, ensuring a healthier future for those affected by HG and for generations to come.
“Marlena Fejzo miscarried two decades ago due to hyperemesis gravidarum (HG), an extreme form of morning sickness that can cause violent illness. Dismissed by doctors who told Fejzo she was exaggerating her symptoms, the Harvard-educated Ph.D. set about conducting a series of genetic studies that have, in the past six years, produced breakthrough findings revealing the gene responsible for HG. With HG’s genetic mechanisms now known, Fejzo is turning her attention toward treating and preventing the condition for patients.”
Forbes
Dr. Fejzo’s Interview on NBC News
Don’t miss this inspiring interview where Dr. Fejzo shares her personal Hyperemesis Gravidarum (HG)* journey, the incredible discovery of the major genetic cause of this debilitating disease, and what’s on the horizon for the future.
Hyperemesis Gravidarum, HG, is a much more severe form of morning sickness often leading to dehydration, weight loss and other symptoms. @DrFejzo turned her grief into research after suffering from HG pic.twitter.com/OHRLdqtGpq
— Kate Snow (@tvkatesnow) August 3, 2024
Video credits: NBC News
International Colloquium on Hyperemesis Gravidarum (ICHG) 2024
Dive into the details of the upcoming biennial conference, ICHG 2024, happening for the first time in the United States. Join us November 6-7, 2024, in Ventura, California (near Los Angeles) for two days of engaging with top scientists and clinicians specializing in HG management. Patients and advocates are also invited to attend. Registration and details >>>
The cause of Hyperemesis Gravidarum (HG) has been found, and it’s not hCG!
The research study published in Nature revealed that abnormally high levels of the hormone GDF15 and increased sensitivity to it are the major factors contributing to HG. Continue reading >>>
From HG Loss To HG Discovery
Dr. Marlena Fejzo and Kimber MacGibbon’s historical timeline that sets the stage for testing novel treatments for Nausea and Vomiting during Pregnancy (NVP) and Hyperemesis Gravidarum (HG). Follow the journey >>>
TIME Woman of the Year 2024 Honoree
TIME named Dr. Marlena Fejzo to its annual TIME Women of the Year list, recognizing extraordinary leaders fighting for a more equal world. Continue reading >>>
*Hyperemesis Gravidarum (HG) is a debilitating and potentially life-threatening pregnancy disease marked by rapid weight loss, malnutrition, and dehydration due to unrelenting nausea and/or vomiting with potential adverse consequences for the mom-to-be and the newborn(s).
GET INVOLVED
